Gli altri portali
Notizie
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
Kolmar Korea Named Among TIME's World's Best Companies in Sustainable Growth…
Only ten Korean companies made the list this year — down by 13 compared to last year — and Kolmar Korea was the only Korean cosmetics company to be ranked for two consecutive years. Only ten Korean companies made the list this year — down by 13 compared to last year — and Kolmar Korea was the only Korean cosmetics company to be ranked for two consecutive years. The evaluation was based on three equally weighted factors —revenue growth, financial stability, and environmental impact— on a...
PR Newswire
20/11/2025
ZINZINO AB (PUBL.): Share subscription due to warrants
The total number of B shares increased by 42,000 to 31,206,148. The total number of shares after the increase was 36,319,540. The dilution amounted to 0.12 percent. Zinzino's share capital increased to SEK 3,631,954. The total number of B shares increased by 42,000 to 31,206,148. The total number of shares after the increase was 36,319,540. The dilution amounted to 0.12 percent. Zinzino's share capital increased toSEK 3,631,954. For more information: Dag Bergheim Pettersen CEO...
PR Newswire
20/11/2025
Evaxion announces positive data for lead antigens in cytomegalovirus (CMV)…
Evaxion’s AI-Immunology™ platform has discovered novel CMV antigens that significantly reduce viral infection in preclinical models EVX-V1 is a next-generation, multi-component vaccine program combining these novel AI-discovered antigens with AI-optimized versions of established CMV vaccine antigensEvaxion’s proprietary AI-optimized pre-fusion glycoprotein B (gB) antigen demonstrates superior performance compared to the traditional gB antigen, including enhanced CMV neutralization...
Nasdaq GlobeNewswire
20/11/2025
CapVest recapitalizes Curium to accelerate its growth strategy, marking the…
Curium and CapVest have announced the recapitalization of Curium via a new Continuation Vehicle The transaction values Curium at circa $7 billion, representing the largest transaction in nuclear medicine globally The recapitalization will accelerate Curium’s strategy to launch innovative, life-changing diagnostic and therapeutic solutions for cancer patients around the worldBOSTON, Nov.20, 2025(GLOBE NEWSWIRE) -- Curium, a leading producer of radiopharmaceuticals, and CapVest...
Nasdaq GlobeNewswire
20/11/2025
Lappset launches new Prime collection
Industrial News Service
20/11/2025
NASH/MASH Treatment Market to Surpass USD 31.76 Billion by 2033 as…
More than 80% of late-stage pipeline candidates are metabolic and fibrotic-targeted therapies-ranging from GLP-1 agonists, FGF21 analogues, PPAR agonists, THR-β agonists, ACC inhibitors, and dual agonists-positioning the MASH landscape for unprecedented transformation between 2025 and 2033. More than 80% of late-stage pipeline candidates are metabolic and fibrotic-targeted therapies-ranging fromGLP-1 agonists, FGF21 analogues, PPAR agonists, THR-β agonists, ACC inhibitors, and dual agonists...
PR Newswire
20/11/2025
Dreame's Biggest Black Friday Deals of the Year - Save Up to £450 on our…
Unlock unbeatable deals of the year on Dreame's top-rated products for a smarter, cleaner home Dreame Aqua10 Ultra Roller CompleteEfficient, Thorough Cleaning The Dreame Aqua10 Ultra Roller Complete features ProLeap™ retractable robot legs to tackle thresholds and uneven terrain up to8 cm. AquaRoll™ technology ensures self-cleaning with fresh water and separates dirty water to prevent re-contamination. Its FluffRoll™ technology, rotating at 1,000 RPM,...
PR Newswire
20/11/2025
Alvotech and Advanz Pharma Receive Marketing Approval Across the European…
Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Advanz Pharma Holdco Limited (“Advanz Pharma”), a UK headquartered global pharmaceutical company with a strategic focus on specialty, hospital, and rare disease medicines in Europe, today announced that the European Commission (EC) has granted marketing authorizations in the European Economic Area (EEA) for Gobivaz®, Alvotech’s biosimilar to...
Nasdaq GlobeNewswire
20/11/2025
IMU Biosciences Appoints Dr. Carlos Paya as Non-Executive Director…
PRESS RELEASELondon, UK, 20 November 2025 — IMU Biosciences (or “the Company”), a biotechnology company decoding the immune system to drive next generation health outcomes, today announced the appointment of Dr. Carlos Paya as Non-Executive Director.Carlos has a distinguished track record of leadership spanning academic medicine and the biopharmaceutical industry, with deep expertise in drug development and commercial strategy across early-stage start-ups to large-cap pharmaceutical...
Nasdaq GlobeNewswire
20/11/2025
Smartee Deepens Its Strategy for Central Asia and Russia in 2025
In addition to its exhibition presence, Smartee continued its educational mission by hosting the GS Mandibular Repositioning Academic Forum in Almaty. The forum featured in-depth training sessions and live case discussions, offering local orthodontists insights into Smartee's pioneering approach to mandibular repositioning and functional orthodontic therapy. This initiative strengthened professional ties and solidified Smartee's role in advancing clinical practices in the region. In addition…
PR Newswire
20/11/2025
Third quarter 2025 update: IBA is highly confident to meet FY2025 guidance, and…
Louvain-la-Neuve, Belgium, 20 November 2025- IBA (Ion Beam Applications SA), the world leader in particle accelerator technology, shares its business update for the third quarter of 2025.Group Overview Equipment order intake at €195 millionas of Q3 2025 (+6% vs. last year) with a strong contribution from IBA Technologies (+22%) driven by RadioPharma Solutions, and four Proteus ® ONE solutions sold within IBA Clinical. Equipment and Services backlog stable at €1.3 billion,...
Nasdaq GlobeNewswire
20/11/2025
Valneva Reports Nine-Month 2025 Financial Results and Provides Corporate Updates
Total revenues of €127.0 million compared to €116.6 million in the first nine months of 2024Cash and cash equivalents of €143.5 million at end of September 2025Financial flexibility enhanced with successful debt refinancing in October 2025 1 Lyme disease Phase 3 study VALOR on trackUpdated 2025 financial outlook confirmed 1Saint-Herblain (France), November 20, 2025 –Valneva SE(Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today reported...
Nasdaq GlobeNewswire
20/11/2025
Novartis projects +5-6% cc sales CAGR 2025-2030, with long-term growth backed by…
Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance rolled forward to +5-6% cc CAGR for 2025-2030, following upgrade of 2024-2029 guidance to +6% cc 1 Peak sales guidance upgraded for Kisqali and Scemblix; Novartis now has eight de-risked, in-market assets with USD 3-10 billion peak sales potential15+ potentially submission-enabling readouts expected in the next two years to fuel long-term growth Pipeline includes 30+ potential high-value medicines, with...
Nasdaq GlobeNewswire
20/11/2025
AIRS Medical Continues Swift Expansion Through Europe, the Middle East, and…
SwiftMR: To Europe and BeyondEstablished in 2024, AIRS Medical Europe GmbH has been steadily spreading SwiftMR's significant efficiency and quality improvements throughout the European healthcare market. SwiftMR: To Europe and BeyondEstablished in 2024, AIRS Medical Europe GmbH has been steadily spreading SwiftMR's significant efficiency and quality improvements throughout the European healthcare market. Already, AIRS Medical has nurtured several partnerships inEurope, including: ...
PR Newswire
20/11/2025
WuXi AppTec Receives Frost & Sullivan's 2025 Global Company of the Year…
Frost & Sullivan evaluates companies through a rigorous benchmarking process across two core dimensions: strategy effectiveness and strategy execution. WuXi AppTec excelled in both, demonstrating its ability to align strategic initiatives with market demand while executing them with precision and scalability. "WuXi AppTec's integrated CRDMO platform continues to redefine what strategic partnership means in the pharmaceutical ecosystem," said Unmesh Lal, Vice President at Frost…
PR Newswire
20/11/2025
KLKB1 Inhibitors Market to Reach New Heights by 2034 Owing to the Launch of…
Key Takeaways from the KLKB1 Inhibitors Market Report Key Takeaways from the KLKB1 Inhibitors Market Report Discover which indication is expected to grab the major KLKB1 inhibitors market share @KLKB1 Inhibitors Market Report Key Factors Driving the KLKB1 Inhibitors Market Rising Prevalence of Hereditary Angioedema The increasing number of patients diagnosed with HAE, a rare genetic disorder that causes severe swelling attacks, is a primary driver. KLKB1 inhibitors...
PR Newswire
19/11/2025
Transactions with shares and linked securities in Genmab A/S made by managerial…
Company AnnouncementCOPENHAGEN, Denmark; November 19, 2025 –Genmab A/S(Nasdaq: GMAB) - In accordance with Article 19 of Regulation No. 596/2014 on Market Abuse and Implementing Regulation 2016/523, this document discloses the data of the transactions made in Genmab A/S (Nasdaq: GMAB) by managerial employees and their closely associated persons.The company’s managerial employees and their closely associated persons have given Genmab A/S power of attorney on their behalf to...
Nasdaq GlobeNewswire
19/11/2025
Novartis announces plans to build flagship manufacturing hub in North Carolina
Expansion represents significant investment in North Carolina and is expected to create 700 new jobs in the state by end of 2030Enables manufacturing of medicines across company’s main therapeutic areas in one geographic locationMarks latest milestone in company’s previously announced $23 billion investment in US infrastructure Basel, November 19, 2025– Novartis, a leading global innovative medicines company, today announced plans to expand its operations in North Carolina,...
Nasdaq GlobeNewswire
19/11/2025
NABR: CITES Standing Committee Issues Assessment of Long-Tailed Macaque Monkey…
Long-tailed macaques are integral to biomedical research globally due to their close biological similarity to humans. Long-tailed macaques are the most commonly studied nonhuman primate species for drug safety assessment. Research with long-tailed macaques has been crucial for advances in regenerative medicine, immunology, cancer, vaccine development and pharmacology. Long-tailed macaques are integral to biomedical research globally due to their close biological similarity to humans....
PR Newswire
19/11/2025
IPSEN - Buy-back programme - Art 5 of MAR - Week 46 - 2025
Aggregated presentation by day and by marketStatement of transactions in own shares from November 10th to November 14th 2025 Name of the issueIdentity code of the issuer(Legal Entity Identifier) Day of the transactionIdentity code of the financial instrument Total daily volume (in number of shares)Daily weighted average purchase price of the sharesMarket (MIC Code)IPSEN549300M6SGDPB4Z94P1110/11/2025FR0010259150 300 ...
Nasdaq GlobeNewswire
19/11/2025
Vascular Imaging Market worth US$4.54 billion by 2030 with 7.3% CAGR |…
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247188200 Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=247188200 Browse in-depth TOC on "Vascular Imaging Market" 320 - Tables 45 - Figures 323 - Pages By product,the global vascular imaging market is segmented into systems & consoles, accessories & consumables, and software & services. Systems and consoles account for the largest market share...
PR Newswire
19/11/2025
Compounding Chemotherapy Market to Reach $6.3 Billion by 2027 in the short run…
Request Sample of the Report on Compounding Chemotherapy Market Forecast 2034 – https://www.alliedmarketresearch.com/request-sample/A11418 Request Sample of the Report on Compounding Chemotherapy Market Forecast 2034 –https://www.alliedmarketresearch.com/request-sample/A11418 Market Introduction The compounding chemotherapy market involves the preparation of customized chemotherapy medications tailored to individual patient needs. This practice addresses specific requirements...
PR Newswire
19/11/2025
Cell Culture Media Market Outlook: Strong 13.2% CAGR to Drive $12.8 Billion…
Request a free sample copy of this report: Cell Culture Media Market Request a free sample copy of this report:Cell Culture Media Market Innovation in cell culture media also significantly supports the burgeoning field of advanced therapeutics. A notable development occurred inDecember 2024when Mesoblast received FDA approval for Ryoncil (remestemcel-L), marking it as the first and only mesenchymal stromal cell (MSC) therapy approved in the U.S. for treating steroid-refractory acute...
PR Newswire
19/11/2025
Hepatitis B and C Therapeutics Market Surges to US$17.02 Billion in 2024 as…
Buy This Report with Year-End Offer (Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer): https://www.datamintelligence.com/buy-now-page?report=hepatitis-b-and-c-therapeutics-market Buy This Report with Year-End Offer ( Buy 1 report: Get 30% OFF | Buy 2 reports: Get 50% OFF each! Limited time offer):https://www.datamintelligence.com/buy-now-page?report=hepatitis-b-and-c-therapeutics-market Market Dynamics: Strong Push from Antiviral Innovation, Screening...
PR Newswire
19/11/2025
Altri Comunicati
